184 related articles for article (PubMed ID: 20730888)
1. Temsirolimus for metastatic desmoplastic small round cell tumor.
Thijs AM; van der Graaf WT; van Herpen CM
Pediatr Blood Cancer; 2010 Dec; 55(7):1431-2. PubMed ID: 20730888
[TBL] [Abstract][Full Text] [Related]
2. Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.
Jafri M; Douis H; Porfiri E
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):657-8. PubMed ID: 18644704
[No Abstract] [Full Text] [Related]
3. Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.
Ekshyyan O; Mills GM; Lian T; Amirghahari N; Rong X; Lowery-Nordberg M; Abreo F; Veillon DM; Caldito G; Speicher L; Glass J; Nathan CO
Head Neck; 2010 Dec; 32(12):1619-28. PubMed ID: 20222045
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
Tirado OM; Mateo-Lozano S; Notario V
Oncogene; 2005 May; 24(20):3348-57. PubMed ID: 15782132
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells.
Ohara T; Takaoka M; Toyooka S; Tomono Y; Nishikawa T; Shirakawa Y; Yamatsuji T; Tanaka N; Fujiwara T; Naomoto Y
Cancer Sci; 2011 Jul; 102(7):1344-9. PubMed ID: 21521416
[TBL] [Abstract][Full Text] [Related]
6. [Update on clinical activity of CCI779 (temsirolimus), mTOR inhibitor].
Mounier N; Vignot S; Spano JP
Bull Cancer; 2006 Nov; 93(11):1139-43. PubMed ID: 17145584
[TBL] [Abstract][Full Text] [Related]
7. mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma.
Schedel F; Pries R; Thode B; Wollmann B; Wulff S; Jocham D; Wollenberg B; Kausch I
Oncol Rep; 2011 Mar; 25(3):763-8. PubMed ID: 21240463
[TBL] [Abstract][Full Text] [Related]
8. mTOR kinase inhibitors as a treatment strategy in hematological malignancies.
Grzybowska-Izydorczyk O; Smolewski P
Future Med Chem; 2012 Mar; 4(4):487-504. PubMed ID: 22416776
[TBL] [Abstract][Full Text] [Related]
9. Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.
Malizzia LJ; Hsu A
Clin J Oncol Nurs; 2008 Aug; 12(4):639-46. PubMed ID: 18676330
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Disease: survival benefit of temsirolimus validates a role for mTOR in the management of advanced RCC.
Figlin RA
Nat Clin Pract Oncol; 2008 Oct; 5(10):601-9. PubMed ID: 18607393
[TBL] [Abstract][Full Text] [Related]
11. A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity.
Murphy AJ; Bishop K; Pereira C; Chilton-MacNeill S; Ho M; Zielenska M; Thorner PS
Hum Pathol; 2008 Dec; 39(12):1763-70. PubMed ID: 18703217
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma.
Thelen P; Krahn L; Bremmer F; Strauss A; Brehm R; Loertzer H
Int J Mol Med; 2013 Feb; 31(2):339-46. PubMed ID: 23292124
[TBL] [Abstract][Full Text] [Related]
13. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.
Ladanyi M; Gerald W
Cancer Res; 1994 Jun; 54(11):2837-40. PubMed ID: 8187063
[TBL] [Abstract][Full Text] [Related]
14. Temsirolimus in patients with advanced renal cell carcinoma: an overview.
Bhatia S; Thompson JA
Adv Ther; 2009 Jan; 26(1):55-67. PubMed ID: 19172239
[TBL] [Abstract][Full Text] [Related]
15. Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus.
Piha-Paul SA; Cohen PR; Kurzrock R
J Clin Oncol; 2011 Sep; 29(26):e727-30. PubMed ID: 21844496
[No Abstract] [Full Text] [Related]
16. Results of multimodal treatment for desmoplastic small round cell tumors.
Lal DR; Su WT; Wolden SL; Loh KC; Modak S; La Quaglia MP
J Pediatr Surg; 2005 Jan; 40(1):251-5. PubMed ID: 15868593
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic small round cell tumor in children: a new therapeutic approach.
Al Balushi Z; Bulduc S; Mulleur C; Lallier M
J Pediatr Surg; 2009 May; 44(5):949-52. PubMed ID: 19433176
[TBL] [Abstract][Full Text] [Related]
18. Intra-abdominal desmoplastic small round cell tumor.
Nathan JD; Gingalewsik C; Salem RR
Yale J Biol Med; 1999; 72(4):287-93. PubMed ID: 10907779
[TBL] [Abstract][Full Text] [Related]
19. [Use of mTOR-inhibitors in solid tumors].
Seidel C; Grünwald V
Med Monatsschr Pharm; 2011 Apr; 34(4):116-26; quiz 127-8. PubMed ID: 21528529
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.
Chan S; Scheulen ME; Johnston S; Mross K; Cardoso F; Dittrich C; Eiermann W; Hess D; Morant R; Semiglazov V; Borner M; Salzberg M; Ostapenko V; Illiger HJ; Behringer D; Bardy-Bouxin N; Boni J; Kong S; Cincotta M; Moore L
J Clin Oncol; 2005 Aug; 23(23):5314-22. PubMed ID: 15955899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
